OPEN END TURBO LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Börse Stuttgart 12:45:45 25/05/2024 am IST | ||
| 1.22 EUR | -3.17% |
|
| Current month | -10.29% | ||
| 1 month | -10.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 1.22 | -3.17% |
| 23/24/23 | 1.26 | -3.08% |
| 22/24/22 | 1.3 | -5.80% |
| 21/24/21 | 1.38 | -2.82% |
| 20/24/20 | 1.42 | -4.05% |
Delayed Quote Börse Stuttgart
Last update May 25, 2024 at 12:45 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MB4ENV |
| ISIN | DE000MB4ENV5 |
| Date issued | 15/03/2023 |
| Strike | 35.9 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.49 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.73 € |
|---|---|
| Lowest since issue | 0.42 € |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.34
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.07%
- Stock Market
- Certificates
- Certificat
